The novel benzodiazepine inverse agonist RO19-4603 antagonizes ethanol motivated behaviors: Neuropharmacological studies

Brain Research

Volumn 784, Issue 1-2, 1998, Pages 256-275

  June, Harry L ^a,b   Torres, Lucas ^a   Cason, Charity R ^a   Hwang, Bang H ^c   Braun, Misty R ^a   Murphy, James M ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; Alcohol preferring (P) rat; Benzodiazepine antagonist; Operant responding; RO19 4603; TBPS

Indexed keywords

2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 5 ISOPROPOXY 4 METHYL BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A]THIENO[2,3 F][1,4]DIAZEPINE 3 CARBOXYLIC ACID TERT BUTYL ESTER; ALCOHOL; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; DIAZEPAM; DRUG VEHICLE; FLUMAZENIL; POLYSORBATE 80; RECEPTOR SUBTYPE; RO 14 7437; SACCHARIN;

ALCOHOL CONSUMPTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ALCOHOL INTERACTION; DRUG ANTAGONISM; FEMALE; INSTRUMENTAL CONDITIONING; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTIVATION; NEUROPHARMACOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; VENTRAL TEGMENTUM;

ALCOHOL DETERRENTS; ALCOHOL DRINKING; ANIMALS; AZEPINES; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHLORIDE CHANNELS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; MALE; MICROINJECTIONS; RATS; RECEPTORS, GABA-A; REWARD;

EID: 0032536399     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01380-2     Document Type: Article

References (87)

1. A receptor α3 and α4 subunits mRNAs in the rat brain. Mol. Brain Res. 12:1991;295-314.
2. Balakleevsky A., Colombo G., Fadda F., Gessa G.L. RO19-4603, a benzodiazepine receptor inverse agonist attenuates voluntary ethanol consumption in rats selectively bred for high ethanol preference. Alcohol Alcohol. 25:1990;449-452.
3. E.J. Bockstael, V.M. Pickel, GABA-containing neurons in theventral tegmental area project to the nucleus accumbens in the rat brain. Brain Research, 628:215-221.
4. Areceptor-operated chloride channels: II. Chronic effects of ethanol. J. Pharmacol. Exp. Ther. 253:1990;713-719.
5. Buck K.J., Heather H., Harris R.A. Reversal of alcohol dependence and tolerance by a single administration of flumazenil. J. Pharmacol. Exp. Ther. 257:1991;984-989.
6. Cason C.R., June H.L., Matecka D., Murphy J.M. Effects of the selective, high affinity ligand ZG-63 for diazepam insensitive subtype of the benzodiazepine receptor on EtOH-reinforced responding. Alcohol. Clin. Exp. Res. 20:1996;12A. [abstract] #15.
7. Churchill L., Kalivas P.W. A topographical organized GABA projection from the ventral pallidum to the nucleus accumbens in the rat. J. Comp. Neurol. 345:1994;579-595.
8. A receptors, in: G. Biggio, E. Costa (Eds.), GABA and Benzodiazepine Receptor Subtypes, Raven Press, New York (1990) pp. 89-108.
9. Craig K., June H.L., Braun M.R., Murphy J.M. Benzodiazepine receptor antagonists modulate the behavioral actions of ethanol. Alcohol. Clin. Exp. Res. 20:1996;13A. [abstract].
10. Duka T., Stephens D.N., Krause W., Dorrow R. Human studies on the benzodiazepine receptor antagonist beta-carboline, ZK 93426: Preliminary observations on psychotropic activity. Psychopharmacology. 93:1987;421.
11. T. Duka, R. Dorrow, Human experimental psychopharmacology of benzodiazepine receptor inverse agonists and antagonists, in: M. Sarter, D.J. Nutt, R.G. Lister (Eds.), Benzodiazepine Receptor Inverse Agonists, Wiley-Liss, New York (1995) pp. 243-270.
12. 35S]-t-butylbi-cyclophosphorothionate binding in the rat brain. An autoradiographic study. J. Neurosci. 10:1990;603-612.
13. File S.E., Pellow S. Intrinsic actions of the benzodiazepine receptor antagonist RO15-1788. Psychopharmacology (Berlin). 88:1986;1-11.
14. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neuro. 359:1995;154-194.
15. Gardner C.R. Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum. Progress Neurobiol. 31:1988;425.
16. Gardner C.R., Budhram P., Parker F.L. Discriminative stimulus properties of RU33965, a benzodiazepine receptor weak partial inverse agonist. Pharmacol. Biochem. Behav. 43:1992;583-588.
17. Giorgi O., Corda M.G., Fernandez A., Biggio G. The β-carboline derivatives ZK 93426 and FG 7142 fail to precipatate abstinence signs in diazepam-dependent cats. Pharmacol. Biochem. Behav. 43:1989;583.
18. A receptors. Neuropharmacol. 35:1996;1307-1314.
19. Gu Z.G., Wong G., Doiminguez C., de Costa B.R., Rice K.C., Skolnock P. Synthesis and evaluation of imidazo[1,5-a]benzodiazepine esters with high affinities at 'diazepam insensitive' benzodiazepine receptors. J. Med. Chem. 36:1993;1001-1006.
20. Harris C.M., Lal H. Central nervous system effects of RO15-4513. Drug Dev. Res. 13:1988;187-203.
21. A receptor to the alcohol antagonistic properties of RO15-4513 and related imidazobenzodiazepines. Pharmacol. Biochem. Behav. 52:1995;113-118.
22. Hodge C.W., Chappelle A.M., Samson H.H. GABAergic transmission in the nucleus is involved in the termination of ethanol self-administration. Alcohol. Clin. Exp. Res. 19:1996;1486-1493.
23. Hwang B.H., Lumeng L., Wu J.Y., Li T.-K. Increased number of GABAergic terminals in the nucleus accumbens is associated with alcohol preference in rats. Alcohol. Clin. Exp. Res. 14:1990;503-507.
24. Hwang B.H., Wang G.-M. A rapid and sensitive radioimmunohistochemical assay for quantification of vassopressin in discrete brain regions with an anatomical resolution. J. Neurosci. Methods. 50:1993;37-44.
25. A receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur. J. Pharmacol. 283:1995;151-159.
26. 3H] RO15-4513 binding in the rodent brain and cultured cerebellar neuronal cells. Neurochem. Res. 19:1994;289-295.
27. H.C. Jackson, D.J. Nutt, Inverse agonist and alcohol, in: M. Sarter, D.J. Nutt, R.G. Lister (Eds.), Benzodiazepine Receptor Inverse Agonists., Wiley-Liss, New York (1995), pp. 243-270.
28. Jensen L.H., Peterson E.N., Braestrup C., Honore T., Kehr W., Stephens D.N., Schnieder H.D., Seidelmann H., Schmiechen R. Evaluation of the β-carboline ZK 93 426 as a benzodiazepine receptor antagonist. Psychopharmacology (Berlin). 83:1984;249-256.
29. June H.L., Hughes R.W., Spurlock H.L., Lewis M.J. Ethanol self-administration in freely feeding rats: effects of RO15-4513 alone, and in combination with flumazenil. (RO15-1788). Psychopharmacology (Berlin). 115:1994;332-339.
30. June H.L., Murphy J.M., Mellor-Burke J.J., Lumeng L., Li T.-K. RO19-4603 exerts prolonged and selective suppression of ethanol intake in the alcohol-preferring (P) rats. Psychopharmacology (Berlin). 115:1994;332-339.
31. June H.L., Duemler S., Greene T.L., Williams J., Lin M., Chen S.H.A., Lewis M.J., Murphy J.M. Effects of RO19-4603 on the maintenance of tolerance to a single dose of ethanol. J. Pharmacol. Exp. Ther. 247:1995;1105-1112.
32. June H.L., Lin M., Greene T.L., Lewis M.J., Murphy J.M. Effects of negative modulators of GABAergic efficacy on ethanol intake: correlation of biochemical changes with pharmacological effect using behavioral paradigm. J. Exp. Clin. Psychopharmacol. 3:1995;252-260.
33. June H.L., Murphy J.M., Hewitt R.L., Greene T.L., Lin M., Mellor-Burke J., Lumeng L., Li T.-K. Benzodiazepine receptor ligands with different intrinsic efficacies alter ethanol intake in alcohol-nonpreferring (NP) rats. Neuropsychopharmacology. 14:1996;55-66.
34. June H.L., Greene T.L., Murphy J.M., Hite M.L., Williams J.A., Cason C.R., Mellor-Burke J., Cox R., Duemler S.E., Torres L., Lumeng L., Li T.-K. Effects of the benzodiazepine inverse agonist RO19-4603 alone and in combination with the b benzodiazepine receptor antagonists flumazenil, ZK 93426, and CGS 8216, on ethanol intake in alcohol-preferring (P) rats. Brain Res. 734:1996;19-34.
35. June H.L., Hwang B.H., Murphy J.M. GABA ergic transmission in the mesoaccumbens is involved in alcohol reinforcement. Alcohol Alcoholism. 32:1997;337.
36. Johnson P.I., Napier T.C. Contribution of the nucleus accumbens to cocaine-induced responses of ventral pallidal neurons. Synapse. 22:1996;253-260.
37. Klotz U. Drug interactions and clinical pharmacokinetics of flumazenil. Eur. J. Anaesthesiol. 2:1988;103-108.
38. Koob G.F., Bloom F.E. Cellular and molecular mechanism of drug dependence. Science. 242:1988;715-723.
39. G.F. Koob, Neural mechanism of drug reinforcement, in: P.W. Kalivas, H.H. Samson (Eds.), Neurobiology of drug and alcohol addiction, Ann NY Acad Sci, 654, 1992a, pp. 171-192.
40. Koob G.F. Drug abuse: anatomy, pharmacology and function of reward pathways. TIPS. 13:1992;177-184.
41. 3H]RO15-4513 binding, in: G. Biggio, A. Concas, E. Costa (Eds.), GABAergic Synaptic Transmission, Raven Press, New York (1992), pp. 289-299.
42. 3H]RO15-4513 binding sites. Eur. J. Pharmacol. 213:1992;323-329.
43. A receptors in the actions of alcohol and in alcoholism: Recent advances. Alcohol Alcohol. 29:1993;115.
44. A binding in the amygdala and hypothalamus of spontaneously hypertensive rats. Brain Res. Bull. 187:1995;123-127.
45. T.-K. Li, D.W. Crabb, L. Lumeng, Molecular and genetic approaches to understanding alcohol-seeking behavior, in: R.E. Meyer, G.F. Koob, M.J. Lewis, S.L. Paul (Eds.), Neuropharmacology of Ethanol, Birhauser, Boston (1991) pp. 107-124.
46. Lister R.G., Greenbalt D.J., Abernethy D.R., File S.E. Pharmacokinetic studies on RO15-1788, a benzodiazepine receptor ligand in the brain of the rat. Brain Res. 290:1984;183-186.
47. Lüddens H., Pritchett D.B., Kohler M., Killisch I., Keinanen K., Monyer H., Sprengel R., Seeburg D.B. Cerebellar GABAa receptor selective for a behavioral alcohol antagonist. Nature. 346:1990;648-651.
48. A/benzodiazepine receptor heterogeneity: Neurophysiological implications. Neuropharmacol. 34:1995;245-254.
49. L. Lumeng, J.M. Murphy, W.J. McBride, T.-K. Li, Genetic influences on alcohol preference in animals, in: H. Begleiter, B. Kissin (Eds.), The Genetics of Alcoholism, Oxford Univ. Press, New York (1995), pp. 165-201.
50. Mandema J.W., Kuck M.T., Danhoff M. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy. J. Pharmacol. Exp. Ther. 261:1992;56-61.
51. 3H] RO15-4513 binding in intact cultured cerebellar granule cells. Eur. J. Pharmacol. 169:1989;53-60.
52. McBride W.J., Murphy J.M., Lumeng L., Li T.-K. Effects of RO15-4513, fluoxetine, desipramine on the intake of ethanol, water and food by the alcohol-preferring (P) and nonpreferring (NP) lines of rats. Pharmacol. Biochem. Behav. 30:1988;1045-1050.
53. W.J. McBride, J.M. Murphy, L. Lumeng, T.-K. Li, Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats, Annual Review of Addiction Research and Treatment., Pergamon, New York (1992), pp. 193-202.
54. Mhatre M., Ticku M.K. Chronic ethanol treatment selectively increases the binding of inverse agonist. J. Pharmacol. Exp. Ther. 251:1989;164-168.
55. Miller L.G., Greenblatt D.J., Barnhill J.G., Summer W.R., Shader R.I. 'GABA shift' in vivo by modulation of endogenous GABA. Eur. J. Pharmacol. 148:1988;123-130.
56. Murphy J.M., Gatto G.J., Waller M.B., McBride W.J., Lumeng L., Li T.-K. Effects of scheduled access on ethanol intake by the alcohol-preferring (P) line of rats. Alcohol. 3:1986;331-336.
57. Paterson M.E., Blakley G.G., Lewis M.J. RO19-4603 produces attenuation of oral self-administration of ethanol for up to 48 h in randomly bred rats. Alcohol. Clin. Exp. Res. 20:1996;52. [abstract].
58. G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates, Academic Press, Orlando, FL (1986).
59. Pieri L. RO19-4603: A benzodiazepine receptor partial inverse agonist with prolonged proconvulsant action in rodents. Br. J. Pharmacol. 95:1988;477. [abstract].
60. A.G. Phillips, H.C. Fibger, Dopamine and motivated behavior: Insights provided by in vivo analyses, in: P. Wilner, J. Scheel-Kruger (Eds.), The Mesolimbic Dopamine System: From Motivation to Action, Wiley, New York (1991), pp. 199-224.
61. Rassnick S.E., D'Amico E., Riley E., Koob G.F. GABA antagonist and benzodiazepine partial inverse agonist reduces motivated responding for ethanol. Alcohol. Clin. Exp. Res. 17:1993;124-130.
62. Samson H.H., Harris R.A. Neurobiology of alcohol abuse. TIPS. 13:1992;206-211.
63. Samson H.H. Initiation of ethanol reinforcement using a surcrose-substitution procedure in food-and water-sated rats. Alcohol. Clin. Exp. Res. 10:1986;436-442.
64. H.H. Samson, Initiation of ethanol maintained behavior: a comparison of animals models and their implication to human drinking, in: T. Thompson, P. Dews, J. Barret (Eds.), Advances in Behavioral Pharmacology: Neurobehavioral Pharmacology, Vol. 6, Erlbaum Associates, New Jersey (1987), pp. 221-241.
65. H.H. Samson, C.W. Hodge, Neurobehavioral regulation of ethanol intake, in: R.A. Deitrich, V.G. Erwin (Eds.), Pharmacological Effects of Ethanol on the Nervous System, CRC Press, New York (1996), pp. 203-226.
66. A coupled chloride channel. J. Pharmacol. Exp. Ther. 256:1991;922-928.
67. Schwarz-Stevens K., Samson H.H., Tolliver G.A., Lumeng L., Li T.-K. The effects of ethanol initiation procedures on ethanol reinforced behavior in the alcohol-preferring rat. Alcohol. Clin. Exp. Res. 15:1991;277-285.
68. Skolnick P., Schweri M.M., Williams E.F., Moncada V.Y., Paul S.M. An in vitro binding assay which differentiates benzodiazepine 'agonists' and 'antagonists'. Eur. J. Pharmacol. 78:1982;133-138.
69. Suzdak P.D., Glowa J.R., Crawley J.N. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science. 234:1986;1243-1247.
70. 35S]-TBPS binding by the occupation of benzodiazepine receptor with its ligands. Eur. J. Pharmacol. 91:1983;145-146.
71. M.K. Ticku, M. Mhatre, A.K. Mehta, Modulation of GABAergic transmission by ethanol, in: G. Biggio, A. Concas, E. Costa (Eds.), GABAergic Synaptic Transmission, Raven Press, New York (1992), pp. 255-268.
72. Turner D.M., Sapp D.W., Olsen R.W. The benzodiazepine/alcohol antagonist RO15-4513: Binding to a GABAa receptor subtype that is insensitive to diazepam. J. Pharmacol. Exp. Ther. 257:1991;1236.
73. 3H] RO15-4513, in cerebellar membranes from two rat lines developed for high and low alcohol sensitivity. J. Neurochem. 54:1990;1980-1987.
74. L subunit. Neuron. 7:1991;27-33.
75. Wegelius K., Honkanen A., Korpi E.R. Benzodiazepine receptor ligands modulate ethanol drinking in alcohol-preferring rats. Eur. J. Pharmacol. 263:1994;141-147.
76. Weiss F., Mitchiner M., Bloom F.E., Koob G.F. Free-choice responding for ethanol versus water in alcohol-preferring (P) and unselected Wistar rats is differentially altered by naloxone, bromocriptine, and methysergide. Psychopharmacol. 101:1990;178-186.
77. F. Weiss, G.F. Koob, Neuropharmacology of ethanol, in: R.E. Meyer, G.F. Koob, M.J. Lewis, S.M. Paul (Eds.), Neuropharmacology of Ethanol, Birkhauser, Boston (1991), pp. 49-76.
78. 4 subunit. FEBS Lett. 289:1991;227-230.
79. A receptor subunit mRNAs in the rat brain I Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12:1992;1040-1062.
80. Wong G., Skolnick P. High affinity ligands for 'diazepam-insensitive' benzodiazepine receptors. Eur. J. Pharmacol. 225:1992;63-68.
81. A/benzodiazepine receptors. Med. Chem. Res. 32:1992;217-224.
82. 3H]tert-butyl-8-chloro-5,6-dihydro-5-methyl-oxo-4H-imidazo[1,5a] benzodiazepine-3-carboxylate (ZG-63). Eur. J. Pharmacol.-Mol. Pharmacol. 247:1993;57-64.
83. A receptor. J. Pharmacol. Exp. Ther. 266:1993;570.
84. Wood P.L., Loo P., Braunwalder A., Yokoyama M., Cheney D.L. In vitro characterization of benzodiazepine receptor agonists, antagonists, inverse agonists and agonists/antagonists. J. Pharmacol. Exp. Ther. 231:1984;572.
85. 4 subunit. Eur. J. Pharmacol. 291:1995;319-325.
86. A receptors. J. Med. Chem. 38:1995;1679-1688.
87. Zhang W., Koehler K.F., Zhang P., Cook J.M. Development of a comprehensive pharmacophore model for the benzodiazepine receptor. Drug Design and Discovery. 12:1995;193-248.